Ritlecitinib: Alopecia
The question
To ask the Secretary of State for Health and Social Care, how many health boards have used Ritlecitinib to treat alopecia in the last 12 months.
Answered by Karin Smyth
The NHS Business Services Authority and NHS England only hold prescribing data for ritlecitinib in England. As health is a devolved issue, information relating to the use of ritlecitinib by Scottish health boards would be held by the Scottish health authorities.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →